Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Heres

Showing results (31-40 of 81) with videos related to

Pageof 9
Sort By:
Psychiatry Research|March 25, 2014
Effects of an integrated care program for outpatients with affective or psychotic disordersJohannes Hamann, Stephan Heres, Ute Seemann, et al.
Der Nervenarzt|August 11, 2020
[Spiritual competence in psychiatry and psychotherapy-Barriers and success factors]Eckhard Frick, Philip Ziemer, Stephan Heres, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|September 28, 2020
Shared decision making, aggression, and coercion in inpatients with schizophreniaJohannes Hamann, Miriam John, Fabian Holzhüter, et al.
International Journal of Psychiatry in Clinical Practice|June 12, 2014
Long-term observation of patients successfully switched to risperidone long-acting injectable: A retrospective, naturalistic 18-month mirror-image study of hospitalization rates and therapy costsBirgit Spill, Silvia Konoppa, Werner Kissling, et al.
The Cochrane Database of Systematic Reviews|May 18, 2012
Maintenance treatment with antipsychotic drugs for schizophreniaStefan Leucht, Magdolna Tardy, Katja Komossa, et al.
Schizophrenia Research|January 25, 2011
Oral versus depot antipsychotic drugs for schizophrenia--a critical systematic review and meta-analysis of randomised long-term trialsClaudia Leucht, Stephan Heres, John M Kane, et al.
Psychiatric Services (Washington, D.C.)|August 4, 2009
Psychiatrists' use of shared decision making in the treatment of schizophrenia: patient characteristics and decision topicsJohannes Hamann, Rosmarie Mendel, Rudolf Cohen, et al.
Lancet (London, England)|May 8, 2012
Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysisStefan Leucht, Magdolna Tardy, Katja Komossa, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 25, 2008
Identifying the profile of optimal candidates for antipsychotic depot therapy A cluster analysisStephan Heres, Johannes Hamann, Rosmarie Mendel, et al.
Schizophrenia Bulletin|February 5, 2014
Dose equivalents for second-generation antipsychotics: the minimum effective dose methodStefan Leucht, Myrto Samara, Stephan Heres, et al.
Pageof 9

Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
Psychiatry Research|March 25, 2014
Effects of an integrated care program for outpatients with affective or psychotic disordersJohannes Hamann, Stephan Heres, Ute Seemann, et al.
Der Nervenarzt|August 11, 2020
[Spiritual competence in psychiatry and psychotherapy-Barriers and success factors]Eckhard Frick, Philip Ziemer, Stephan Heres, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|September 28, 2020
Shared decision making, aggression, and coercion in inpatients with schizophreniaJohannes Hamann, Miriam John, Fabian Holzhüter, et al.
International Journal of Psychiatry in Clinical Practice|June 12, 2014
Long-term observation of patients successfully switched to risperidone long-acting injectable: A retrospective, naturalistic 18-month mirror-image study of hospitalization rates and therapy costsBirgit Spill, Silvia Konoppa, Werner Kissling, et al.
The Cochrane Database of Systematic Reviews|May 18, 2012
Maintenance treatment with antipsychotic drugs for schizophreniaStefan Leucht, Magdolna Tardy, Katja Komossa, et al.
Schizophrenia Research|January 25, 2011
Oral versus depot antipsychotic drugs for schizophrenia--a critical systematic review and meta-analysis of randomised long-term trialsClaudia Leucht, Stephan Heres, John M Kane, et al.
Psychiatric Services (Washington, D.C.)|August 4, 2009
Psychiatrists' use of shared decision making in the treatment of schizophrenia: patient characteristics and decision topicsJohannes Hamann, Rosmarie Mendel, Rudolf Cohen, et al.
Lancet (London, England)|May 8, 2012
Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysisStefan Leucht, Magdolna Tardy, Katja Komossa, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 25, 2008
Identifying the profile of optimal candidates for antipsychotic depot therapy A cluster analysisStephan Heres, Johannes Hamann, Rosmarie Mendel, et al.
Schizophrenia Bulletin|February 5, 2014
Dose equivalents for second-generation antipsychotics: the minimum effective dose methodStefan Leucht, Myrto Samara, Stephan Heres, et al.
Pageof 9